Eden Research PLC

Eden Research PLC has a fully diluted share count of 803,362,994 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics for Eden Research PLC are not available in the current dataset, and no industry_config preferred metrics are provided for comparison. The company's revenue and earnings estimates are mixed, with a mean revenue estimate of 4.9 million GBP and a last actual revenue of 4.303 million GBP. Analysts have not provided a positive EPS estimate, with both the mean and last actual EPS at -0.00 GBP. Segment and geographic exposure data are not disclosed in the available source documents, making it impossible to assess revenue concentration or geographic diversification. The company's growth trajectory is uncertain, as no specific numeric deltas or revenue history are provided in the dataset. Analysts have set a mean price target of 20.00 GBP, with the median, high, and low price targets also at 20.00 GBP, indicating a consensus but no directional guidance. Risk factors include the inability to assess liquidity risk and the lack of disclosed dilution potential. No recent events, such as filings or transcripts, are available in the dataset to provide additional context on the company's risk profile.